HiFiBiO Therapeutics closes £55m Series C financing

This article was originally published here

The funding was led by new investor IDG Capital. The existing shareholders Sequoia Capital China, VI Ventures, Legend Star Capital, and LYFE Capital continued to invest. New investors

The post HiFiBiO Therapeutics closes £55m Series C financing appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply